Haemonetics Corp

Most Recent

  • uploads///blood _
    Company & Industry Overviews

    Analysts’ Recommendations for Haemonetics and Peers in March 2018

    In its fiscal 3Q18, which ended on December 31, 2017, Haemonetics (HAE) reported revenue of close to $234 million.

    By Margaret Patrick
  • uploads///medic _
    Earnings Report

    Haemonetics’s Fiscal Q1 Earnings Surpass Analyst Estimates

    Haemonetics reported an 8.7% YoY increase in revenues to $229.3 million during Q1 2019 as compared to revenues of $210.9 million during Q1 2018.

    By Mike Benson
  • uploads///blood _
    Earnings Report

    What Analysts Expect from Haemonetics in Q1 2019

    Haemonetics is expected to report 4.3% growth in revenues to $219.9 million during Q1 2019 as compared to $210.9 million during Q1 2018.

    By Mike Benson
  • uploads///Graph
    Company & Industry Overviews

    Commercial Launch of NexSys PCS May Boost Haemonetics’s Revenues

    Haemonetics is also involved in plasma donor center experience programs that involve the use of NexSys PCS device and YES technology.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    The Hospital Business Remains 1of HAE’s Key Growth Drivers

    In fiscal 3Q18, Haemonetics (HAE) reported revenue of close to $46.7 million in its hospital business, a YoY (year-over-year) rise of ~9.1%.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.